期刊文献+

Pompe病的研究进展 被引量:2

原文传递
导出
摘要 Pompe's病又称为Ⅱ型糖原累积病(glycogen storage disease,typeⅡ,GSDⅡ),由荷兰病理学家Pompe于1932年首先提出〔1〕,是一种由于先天性酸性α-葡萄糖苷(acidα-glucosidase,GAA)缺陷所导致的常染色体隐性遗传性代谢性疾病。近年来,特别是2006年美国FDA批准Myozyme作为Pompe's病的酶替代治疗(enzyme replacement therapy,ERT)药物以来,对GSDII的自然过程、Myozyme的疗效、免疫反应、病理、新生儿筛查、运动规律、陪伴治疗及基因治疗等方面取得了重要的进展,现就近年来研究进展综述如下。
出处 《中国妇幼保健》 CAS 北大核心 2014年第33期5541-5544,共4页 Maternal and Child Health Care of China
  • 相关文献

参考文献3

二级参考文献177

  • 1[14]Lei KJ,Pan CJ,Shelly LL,Liu JL,Chou JY.Identification of mutations in the gene for glucose-6-phosphatase,the enzyme deficient in glycogen storage disease type 1a.J Clin Invest 1994;93:1994-1999
  • 2[15]Yang Chou J,Mansfield BC.Molecular Genetics of Type 1 Glycogen Storage Diseases.Trends Endocrinol Metab 1999; 10:104-113
  • 3[16]Lei KJ,Pan CJ,Shelly LL,Liu JL,Chou JY.Identification of mutations in the gene for glucose-6-phosphatase,the enzyme deficient in glycogen storage disease type 1a.J Clin Invest 1994;93:1994-1999
  • 4[17]Rake JP,Visser G,Labrune P,Leonard JV,Ullrich K,Smit GP.Glycogen storage disease type Ⅰ:diagnosis,management,clinical course and outcome.Results of the European Study on Glycogen Storage Disease Type Ⅰ (ESGSD Ⅰ).Eur J Pediatr 2002;161 Suppl 1:S20-S34
  • 5[18]Rake JP,Visser G,Labrune P,Leonard JV,Ullrich K,Smit GP.Guidelines for management of glycogen storage disease type Ⅰ-European Study on Glycogen Storage Disease Type Ⅰ (ESGSD Ⅰ).Eur J Pediatr 2002; 161 Suppl 1:S112-S119
  • 6[19]Visser G,Rake JP,Kokke FT,Nikkels PG,Sauer PJ,Smit GP.Intestinal function in glycogen storage disease type Ⅰ.J Inherit Metab Dis 2002; 25:261-267
  • 7[20]Pabuccuoglu A,Aydogdu S,Bas M.Serum biotinidase activity in children with chronic liver disease and its clinical significance.J Pediatr Gastroenterol Nutr 2002; 34:59-62
  • 8[21]Saltik IN,Ozen H,Kocak N,Yuce A,Gurakan F.High biotinidase activity in type Ⅰa glycogen storage disease.Am J Gastroenterol 2000; 95:2144
  • 9[22]Burlina AB,Dermikol M,Mantau A,Piovan S,Grazian L,Zacchello F,Shin Y.Increased plasma biotinidase activity in patients with glycogen storage disease type Ⅰa:effect of biotin supplementation.J Inherit Metab Dis 1996; 19:209-212
  • 10[23]Gogus S,Kocak N,Ciliv G,Karabulut E,Akcoren Z,Kale G,Caglar M.Histologic features of the liver in type Ⅰa glycogen storage disease:comparative study between different age groups and consecutive biopsies.Pediatr Dev Pathol 2002; 5:299-304

共引文献308

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部